Stockscreener 앱 받기
1.25
0.79%
-0.01
시간 외 거래:
1.24
-0.01
-0.80%
Heartbeam Inc 주식(BEAT)의 최신 뉴스
HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - USA Today
Aug Catalysts: Is HeartBeam Inc Equity Warrant benefiting from interest rate changesMarket Activity Report & Community Trade Idea Sharing - baoquankhu1.vn
Trend Recap: Is HeartBeam Inc a turnaround storyWeekly Trade Summary & Low Risk High Reward Ideas - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: HeartBeam (BEAT), Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail
H.C. Wainwright reiterates Heartbeam stock rating on commercial progress By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Heartbeam stock rating on commercial progress - Investing.com
Heartbeam Inc reports results for the quarter ended December 31Earnings Summary - TradingView
HeartBeam Shares Fall After Benchmark Maintains Speculative Buy Rating - marketscreener.com
Benchmark Maintains HeartBeam's Rating at Speculative Buy, Price Target is $8 - marketscreener.com
Heartbeam stock jumps after AI collaboration with Mount Sinai - MSN
HeartBeam Shares Fall After Benchmark Downgrade - marketscreener.com
HeartBeam partners with Mount Sinai to advance AI-powered ECG technology - MSN
Benchmark Downgrades HeartBeam to Speculative Buy From Buy, Price Target is $8 - marketscreener.com
HeartBeam (NASDAQ: BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development - USA Today
HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio - USA Today
HeartBeam (BEAT) Q4 2025 Earnings Call Transcript - AOL.com
HeartBeam to present at March investor conferences By Investing.com - Investing.com Nigeria
HeartBeam reports net loss of USD 5.3M in Q4 2025 - Medical Buyer
HeartBeam Earnings Call Balances Breakthroughs With Cash Risk - TipRanks
HeartBeam Q4 2025 slides: FDA clearances fuel commercial launch By Investing.com - Investing.com Australia
HeartBeam (NASDAQ: BEAT) files $100M shelf; $78.8M previously registered unsold - Stock Titan
HeartBeam (BEAT) Reports Q4 and Full-Year 2025 Results, Advances Commercialization and Clinical Development - NewMediaWire
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript - Insider Monkey
HeartBeam, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Precision Neuroscience, founded by Neuralink alums, is developing a competing brain implant that it says is safer - AOL.com
HeartBeam Q4 2025 slides: FDA clearances fuel commercial launch - Investing.com India
Earnings call transcript: HeartBeam Q4 2025 misses EPS, stock rises - Investing.com Nigeria
HeartBeam Q4 2025 Earnings Call Transcript - MarketBeat
HeartBeam, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:BEAT) 2026-03-12 - Seeking Alpha
HeartBeam : Investor Presentation – March 2026 - marketscreener.com
HeartBeam : Fourth Quarter 2025 Earnings Conference Call Presentation - marketscreener.com
HeartBeam Q4 net loss widens - TradingView
BEAT: FDA-cleared at-home ECG, new partnerships, and improved cash position drive growth - TradingView
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
HeartBeam Reports Fourth Quarter and Full Year 2025 Results - The Chronicle-Journal
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
HeartBeam (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences - USA Today
Panic Selling: Can HeartBeam Inc outperform in the next rally2026 Historical Comparison & Proven Capital Preservation Tips - baoquankhu1.vn
HeartBeam announces first commercial customer as ClearCardio brings groundbreaking 12-lead ECG technology to high-growth preventive cardiology market - MSN
HeartBeam partners with Mount Sinai on AI-ECG development By Investing.com - Investing.com Canada
Heartbeam Stock Jumps After AI Collaboration With Mount Sinai - Bitget
HeartBeam advances portable cardiac monitoring platform after FDA clearance - DOTmed
HeartBeam announces first patient enrollments in heart attack detection pilot study - MSN
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study - Stocktwits
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home - Stocktwits
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market - Stocktwits
After Hours: HeartBeam (BEAT) NASDAQ $1.35 (-8.78%) pre-Mar 12 earnings: watch guidance - Meyka
HeartBeam (BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - NewMediaWire
Heartbeam Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
5.94%
자본화:
|
볼륨(24시간):